Amistem
Device Hip
General payments
$4,595,259
Research payments
$262,382
Through program year 2023, $4,595,259 in general payments and $262,382 in research payments were reported against Amistem (Hip).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | General | $800,363 | 1,235 |
| 2022 | General | $540,738 | 965 |
| 2021 | General | $998,824 | 635 |
| 2020 | General | $954,505 | 657 |
| 2020 | Research | $10,560 | 1 |
| 2019 | General | $1,300,828 | 1,618 |
| 2019 | Research | $251,822 | 3 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2023.
The top 5 of 18 specialties; each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.
The top 5 of 38 states; each share is of general payments naming this product in 2023 where a state was reported.
Records
5,110 general · 4 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.